ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 Published on July 2014
Report Summary Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Dong Wha Pharma Co., Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Dong Wha Pharma Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Dong Wha Pharma Co., Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Dong Wha Pharma Co., Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Dong Wha Pharma Co., Ltd.'s pipeline products Reasons to buy
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 1/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! - Evaluate Dong Wha Pharma Co., Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Dong Wha Pharma Co., Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Dong Wha Pharma Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Dong Wha Pharma Co., Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dong Wha Pharma Co., Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Dong Wha Pharma Co., Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Content Table of Contents Dong Wha Pharma Co., Ltd. Snapshot 5 Dong Wha Pharma Co., Ltd. Overview 5 Key Information 5 Key Facts 5 Dong Wha Pharma Co., Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Dong Wha Pharma Co., Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Dong Wha Pharma Co., Ltd. - Pipeline Products Glance 10 Dong Wha Pharma Co., Ltd. - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Dong Wha Pharma Co., Ltd. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Dong Wha Pharma Co., Ltd. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Dong Wha Pharma Co., Ltd. - Drug Profiles 15 zabofloxacin 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 DW-1029M 17 Product Description 17 Mechanism of Action 17 R&D Progress 17
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 2/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! DW-167 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 DW-1350 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 DW-1006 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Drug for Stroke 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Dong Wha Pharma Co., Ltd. - Pipeline Analysis 23 Dong Wha Pharma Co., Ltd. - Pipeline Products by Target 23 Dong Wha Pharma Co., Ltd. - Pipeline Products by Route of Administration 24 Dong Wha Pharma Co., Ltd. - Pipeline Products by Molecule Type 25 Dong Wha Pharma Co., Ltd. - Pipeline Products by Mechanism of Action 26 Dong Wha Pharma Co., Ltd. - Recent Pipeline Updates 27 Dong Wha Pharma Co., Ltd. - Dormant Projects 28 Dong Wha Pharma Co., Ltd. - Locations And Subsidiaries 29 Head Office 29 Other Locations & Subsidiaries 29 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 32 Disclaimer 32
List of Tables Dong Wha Pharma Co., Ltd., Key Information 5 Dong Wha Pharma Co., Ltd., Key Facts 5 Dong Wha Pharma Co., Ltd. - Pipeline by Indication, 2014 7 Dong Wha Pharma Co., Ltd. - Pipeline by Stage of Development, 2014 8 Dong Wha Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 Dong Wha Pharma Co., Ltd. - Phase III, 2014 10 Dong Wha Pharma Co., Ltd. - Phase II, 2014 11 Dong Wha Pharma Co., Ltd. - Phase I, 2014 12 Dong Wha Pharma Co., Ltd. - Preclinical, 2014 13 Dong Wha Pharma Co., Ltd. - Discovery, 2014 14
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 3/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Dong Wha Pharma Co., Ltd. - Pipeline by Target, 2014 23 Dong Wha Pharma Co., Ltd. - Pipeline by Route of Administration, 2014 24 Dong Wha Pharma Co., Ltd. - Pipeline by Molecule Type, 2014 25 Dong Wha Pharma Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 26 Dong Wha Pharma Co., Ltd. - Recent Pipeline Updates, 2014 27 Dong Wha Pharma Co., Ltd. - Dormant Developmental Projects,2014 28 Dong Wha Pharma Co., Ltd., Other Locations 29
List of Figures Dong Wha Pharma Co., Ltd. - Pipeline by Top 10 Indication, 2014 7 Dong Wha Pharma Co., Ltd. - Pipeline by Stage of Development, 2014 8 Dong Wha Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014 9 Dong Wha Pharma Co., Ltd. - Pipeline by Top 10 Target, 2014 23 Dong Wha Pharma Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014 24 Dong Wha Pharma Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014 25 Dong Wha Pharma Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014 26
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 4/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 500.00
Quantity: _____
Site License--USD 3 000.00
Quantity: _____
Corporate License--USD 4 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 5/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014 (From Issuu)
Page 6/6